Amazon Biotech, Inc. Announces the Appointment of Meir Spear, CPA as the Company's Internal Accountant
Amazon Biotech, Inc. (OTC Bulletin Board: AMZB - News), a pharmaceutical company developing and producing a potential immunomodulator drug, developed for use in the treatment of the HIV virus, today announced that it has retained the services of Meir Spear, CPA from the firm of Spear & Co. CPAs as Amazon Biotech's internal accountant (not independent auditors). Meir Spear received his Bachelors of Science in Accounting from Touro College, NY. He has over 9 years of experience in public accounting and 4 years of experience working for one of New York's top 15 accounting firms, servicing the needs of large and small businesses with their tax and accounting needs. About Amazon Biotech, Inc. Amazon Biotech, Inc. is a natural plant pharmaceutical company, primarily developing immune modulator drugs. AMZ 0026 is the company's first such drug, to be used for the treatment of HIV/AIDS. The company intends to initiate Phase I/II clinical studies of AMZ 0026 shortly, with an eventual goal of a joint venture with a major pharmaceutical company in Phase III trials, or to seek to qualify for the FDA Fast Track program to market. Amazon Biotech specializes in natural plant pharmaceutical drugs and is focused on bringing healthier pharmaceutical drugs to market. Additional information on Amazon Biotech may be found at http://www.amazonbiotech.com. Forward-Looking Statements "Safe-Harbor" Statement Under the Private Securities Litigation Reform Act of 1995. This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, including statements regarding any potential sales of products as well as statements that include the words "believes," "expects," "anticipates," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Amazon Biotech, to differ materially from those implied or expressed by such forward-looking statements. Such factors include, among others, the risk factors included in Amazon Biotech's reports filed with the Securities and Exchange Commission under the Exchange Act. This press release speaks as of the date first set forth above and Amazon Biotech assumes no responsibility to update the information included herein for events occurring after the date hereof. You may register to receive Amazon Biotech's future press releases and to be added to the Company's distribution list by visiting: http://www.roiny.com/form.php. Investor Relations Contact: Andrea Costa Robert Giordano ROI Group Associates, Inc. ROI Group Associates, Inc. Phone: (212) 495-0200 x14 Phone: (212) 495-0200 x10 Fax: (212) 495-0746 Fax: (212) 495-0746 [EMAIL PROTECTED] [EMAIL PROTECTED] http://www.roiny.com --------------------------------------------------------------------- ----------- Source: Amazon Biotech, Inc. http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ http://www.arizonabiotech.com/index.php http://www.arizonabiotech.com/ <a href="http://www.arizonabiotech.com/";>Arizona Biotech</a> http://groups.yahoo.com/group/biotech-news/ <a href="http://groups.yahoo.com/group/biotech-news/";>Biotech News</a> http://www.arizonaentrepreneurs.com/ <a href="http://www.arizonaentrepreneurs.com/";>Arizona Entrepreneurs</a> http://www.azhttp.com/ <a href="http://www.azhttp.com/";>Arizona High Tech</a> Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
